Nom du produit:4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N,N-dimethylbenzamide

IUPAC Name:4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluoro-N,N-dimethylbenzamide

CAS:1443331-78-9
Formule moléculaire:C22H18F4N4O2S
Pureté:95%+
Numéro de catalogue:CM1079058
Poids moléculaire:478.47

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1443331-78-9
Formule moléculaire:C22H18F4N4O2S
Point de fusion:-
Code SMILES:N#CC1=CC=C(C=C1C(F)(F)F)N2C(=O)C(N(C3=CC=C(C(F)=C3)C(=O)N(C)C)C2=S)(C)C
Densité:
Numéro de catalogue:CM1079058
Poids moléculaire:478.47
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Fluorinated Compounds
Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.